CompletedPhase 4

Comparison of Tamsulosin and Solifenacin in Treatment of Ureteral Stent Symptoms

Egypt131 participantsStarted 2013-01

Plain-language summary

This study will be conducted to compare the effectiveness of alpha blocker (Tamsulosin) and Anticholinergic (Solifenacin) in relieving lower urinary tract symptoms caused DJ ureteral stents.

Who can participate

Age range20 Years – 50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. To relieve upper urinary tract obstruction caused by ureteric calculi
✓. After ureteroscopic lithotripsy for ureteral calculi.

Exclusion criteria

✕. Patients who had LUTS before stent fixation.
✕. Ureteral stent fixation after open or laparoscopic surgery.
✕. Bilateral ureteral stents.
✕. Patients who developed complications related to the primary endoscopic procedure
✕. Patients who developed stent related complications such as hematuria, acute pyelonephritis or stent displacement

What they're measuring

The Efficacy of tamsulosin and solifenacin in relieving ureteral stent symptoms will be evaluated by comparing the scores of ureteral stent symptoms questionnaire in the studied groups

Timeframe: 1 year

Trial details

NCT IDNCT01880619

SponsorMansoura University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2014-05

View on ClinicalTrials.gov More Relieve of Ureteral Stent Symptoms trials